OCGN: Ocugen, Inc. Common Stock Company Profile & Statistics

About

Ocugen Inc. is a clinical stage biopharmaceutical company. It is focused on discovering, developing and commercializing therapies which address rare and underserved eye diseases. The company's product pipeline consists of OCU400, OCU300, OCU100 and OCU200 which are in clinical stage. Ocugen Inc., formerly known as Histogenics Cp, is based in Malvern, Pennsylvania.

Info & Links

CEO

Shankar Musunuri

Headquarters

11 GREAT VALLEY PARKWAY
MALVERN, PA 19355, UNITED STATES

Auditor

PricewaterhouseCoopers LLP

Share holders

Employees

Ocugen, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

196.82M

Enterprise Value

166.97M

Enterprise Value/EBITDA(ttm)

-3.16

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

21.87

Price to Book(mrq)

4.96

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-532.51%

Profit Margin(ttm)

-1368.40%

Return on Equity(ttm)

-154.75%

Return on Invested Capital(ttm)

-175.29%

Return on Assets(ttm)

-90.79%

Income Statement

Revenue(ttm)

4.05M

Revenue Per Share(ttm)

0.01

Gross Profit(ttm)

4.05M

EBITDA(ttm)³

-52.79M

Net Income Available to Common(ttm)

-54.05M

Diluted EPS(ttm)

-0.18

Share Statistics

Beta (5Y Monthly)

3.82

52-Week Change

-48.18%

S&P 500 52-Week Change

5.43%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

292.01M

Dividend Yield

0.00%

Float⁴

278.82M

% Held by Insiders

4.29%

% Held by Institutions

10.27%

Balance Sheet

Total Cash(mrq)

58.51M

Total Cash Per Share(mrq)

0.20

Total Debt(mrq)

28.67M

Total Debt/Equity(mrq)

96.76%

Current Ratio(mrq)

2.86%

Quick Ratio(mrq)

2.58%

Book Value Per Share(mrq)

0.10

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.16

Free Cash Flow(ytd)

-45.53M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

OCGN

Ocugen, Inc. Common Stock

Ocugen, Inc. Common Stock Profile